Pregnant again six months after hydatidiform mole

A hydatidiform mole refers to a situation where the embryo does not develop normally and instead forms a grape-like fetal mass. If a pregnant woman is diagnosed with a hydatidiform mole, she will choose to terminate the pregnancy directly because it is difficult for a hydatidiform mole to develop into a healthy fetus. Most of the time, the fetus will be deformed or result in a miscarriage. If a woman becomes pregnant again six months after having a hydatidiform mole, will it be harmful to her? Experts suggest that if you have had a hydatidiform mole before, it is best to consider pregnancy two years later. Let's learn about the specific reasons.

1. Is it dangerous to get pregnant six months after hydatidiform mole?

Hydatidiform mole refers to the proliferation of trophoblastic cells of the placenta villi after pregnancy, severe edema of the interstitium, and the formation of blisters of varying sizes. The blisters are connected in clusters and shaped like grapes, also known as hydatidiform mole (HM). There are two types of hydatidiform mole: complete hydatidiform mole, in which all the placental villi are affected, the entire uterine cavity is filled with blisters, diffuse trophoblastic hyperplasia, and no fetal or embryonic tissue is visible. In partial hydatidiform mole, some placental villi are swollen and degenerated, local trophoblastic cells proliferate, and embryonic and fetal tissues are visible, but the fetus is mostly dead. Sometimes, live fetuses younger than the gestational age or malformed fetuses can be seen, and full-term babies are rarely born. 2. Is it dangerous to get pregnant six months after hydatidiform mole?

Having had a molar pregnancy has no effect on the chances of getting pregnant again, but the possibility of having another molar pregnancy still exists. It is also recommended to consider pregnancy after 2 years. If you become pregnant again six months after a hydatidiform mole, it is recommended that you do a pregnancy check-up, closely observe your physical condition, and go to the hospital for examination and treatment in time if you feel any discomfort. Below, the editor will introduce to you how to prevent hydatidiform mole.

After treatment of hydatidiform mole, attention should be paid to preventing its recurrence. How to prevent hydatidiform mole? Regular follow-up is an important means of prevention. During follow-up, special attention should be paid to changes in hematuria and HCG levels and to understanding of the status of uterine involution.

Under normal circumstances, after the hydatidiform mole is emptied, serum hCG decreases steadily. The average time for the first drop to normal is 9 weeks, and the longest time is no more than 14 weeks. If hCG remains abnormal after the mole is evacuated, gestational trophoblastic tumor should be considered. High-risk hydatidiform mole should be considered when the following high-risk factors are present: hCG>100,000U/L; the uterus is significantly larger than the corresponding gestational age; the diameter of the ovarian luteinized cyst is>6 cm or bilateral luteinized cysts; age 40 years old; small hydatidiform mole; history of repeated hydatidiform mole; pregnancy complications: hyperemesis gravidarum, hyperthyroidism, etc.

Recurrence tendency: After one hydatidiform mole, the risk of another hydatidiform mole is less than 1/50; after two hydatidiform moles, the risk of another hydatidiform mole is 1/6; after three hydatidiform moles, the risk of another hydatidiform mole is 1/2.

To prevent the recurrence of hydatidiform mole, it is important to pay attention to follow-up after treatment. After evacuation of hydatidiform mole, hCG should be measured once a week until 3 consecutive negative results, and then once a month for at least half a year. Thereafter, follow-up can be conducted every six months for a total of 2 years. During follow-up, special attention should be paid to changes in hematuria and HCG. Gynecological examinations should also be performed to understand the state of uterine involution and to note whether the patient has abnormal vaginal bleeding, hemoptysis, or other symptoms of metastatic lesions. Pelvic ultrasound, chest X-ray or CT examination are also performed.